ID

42561

Descripción

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27; ODM derived from: https://clinicaltrials.gov/show/NCT00354302

Link

https://clinicaltrials.gov/show/NCT00354302

Palabras clave

Versiones (2)
  1. 12/1/17 12/1/17 -
  2. 2/9/21 2/9/21 -
Subido en

2 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00354302

Inglés

Eligibility Breast Cancer NCT00354302

1 formularios  
Criteria
Descripción

Criteria

enrolled in and meets eligibility requirements for protocol can-ncic-ma27
Descripción

Enrollment in clinical trial | Clinical Trial Eligibility Criteria Fulfill

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4041024
UMLS CUI [2,1]
C1516637
UMLS CUI [2,2]
C1550543
acceptable quality dual-energy x-ray absorptiometry (dexa) of the l1-l4 postero-anterior spine and hip within 12 weeks prior to randomization on protocol can-ncic-ma27
Descripción

Dual-Energy X-Ray Absorptiometry Lumbar spine Postero-Anterior | Dual-Energy X-Ray Absorptiometry Hip

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1510486
UMLS CUI [1,2]
C3887615
UMLS CUI [1,3]
C1996865
UMLS CUI [2,1]
C1510486
UMLS CUI [2,2]
C0019552
hormone receptor status:
Descripción

Hormone Receptor Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
estrogen receptor- and/or progesterone receptor-positive tumor
Descripción

Estrogen receptor positive tumor | Progesterone receptor positive tumor

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1562312
UMLS CUI [2]
C1562928
patient characteristics:
Descripción

Client Characteristics

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0815172
female
Descripción

Gender

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
postmenopausal
Descripción

Postmenopausal state

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
no malabsorption syndrome
Descripción

Malabsorption Syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024523
no known cholecalciferol (vitamin d) deficiency, active hyper- or hypoparathyroidism, or paget's disease
Descripción

Cholecalciferol Deficiency | Vitamin D Deficiency | Hyperparathyroidism | Hypoparathyroidism | Paget's Disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0008318
UMLS CUI [1,2]
C0011155
UMLS CUI [2]
C0042870
UMLS CUI [3]
C0020502
UMLS CUI [4]
C0020626
UMLS CUI [5]
C1368019
no uncontrolled thyroid disease, cushing's disease, or other pituitary disease
Descripción

Thyroid Disease Uncontrolled | Cushing Syndrome | Pituitary Disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0040128
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0010481
UMLS CUI [3]
C0032002
no other bone disease (including osteomalacia or osteogenesis imperfecta)
Descripción

Bone Disease | Osteomalacia | Osteogenesis Imperfecta

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005940
UMLS CUI [2]
C0029442
UMLS CUI [3]
C0029434
prior concurrent therapy:
Descripción

Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0087111
more than 6 months since prior drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (stratum i)
Descripción

Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C3650929
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C3650929
UMLS CUI [3,1]
C0012544
UMLS CUI [3,2]
C3650929
more than 12 months since prior and no concurrent anticonvulsants
Descripción

Anticonvulsants

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003286
more than 6 months since prior and no concurrent corticosteroids at doses > 5 mg/day of prednisone (or equivalent) for > 2 weeks
Descripción

Adrenal Cortex Hormones Dose Daily | Prednisone Dose Daily | Prednisone Equivalent Dose Daily

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0332173
UMLS CUI [2,1]
C0032952
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0332173
UMLS CUI [3,1]
C0032952
UMLS CUI [3,2]
C0205163
UMLS CUI [3,3]
C0178602
UMLS CUI [3,4]
C0332173
more than 12 months since prior and no concurrent anabolic steroids
Descripción

Anabolic steroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002845
no prior bisphosphonates (stratum ii)
Descripción

Diphosphonates

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012544
no concurrent sodium fluoride at daily doses ≥ 5 mg/day
Descripción

Sodium Fluoride Dose Daily

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0037508
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0332173
no long-term (i.e., > 6 months) use of coumarins
Descripción

Coumarins Long-term

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0010207
UMLS CUI [1,2]
C0443252
no concurrent drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (for patients with no osteopenia or osteoporosis [stratum i])
Descripción

Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis | Osteopenia | Osteoporosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C3650929
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C3650929
UMLS CUI [3,1]
C0012544
UMLS CUI [3,2]
C3650929
UMLS CUI [4]
C0029453
UMLS CUI [5]
C0029456
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00354302

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Enrollment in clinical trial | Clinical Trial Eligibility Criteria Fulfill
Item
enrolled in and meets eligibility requirements for protocol can-ncic-ma27
boolean
C4041024 (UMLS CUI [1])
C1516637 (UMLS CUI [2,1])
C1550543 (UMLS CUI [2,2])
Dual-Energy X-Ray Absorptiometry Lumbar spine Postero-Anterior | Dual-Energy X-Ray Absorptiometry Hip
Item
acceptable quality dual-energy x-ray absorptiometry (dexa) of the l1-l4 postero-anterior spine and hip within 12 weeks prior to randomization on protocol can-ncic-ma27
boolean
C1510486 (UMLS CUI [1,1])
C3887615 (UMLS CUI [1,2])
C1996865 (UMLS CUI [1,3])
C1510486 (UMLS CUI [2,1])
C0019552 (UMLS CUI [2,2])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Estrogen receptor positive tumor | Progesterone receptor positive tumor
Item
estrogen receptor- and/or progesterone receptor-positive tumor
boolean
C1562312 (UMLS CUI [1])
C1562928 (UMLS CUI [2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Gender
Item
female
boolean
C0079399 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal
boolean
C0232970 (UMLS CUI [1])
Malabsorption Syndrome
Item
no malabsorption syndrome
boolean
C0024523 (UMLS CUI [1])
Cholecalciferol Deficiency | Vitamin D Deficiency | Hyperparathyroidism | Hypoparathyroidism | Paget's Disease
Item
no known cholecalciferol (vitamin d) deficiency, active hyper- or hypoparathyroidism, or paget's disease
boolean
C0008318 (UMLS CUI [1,1])
C0011155 (UMLS CUI [1,2])
C0042870 (UMLS CUI [2])
C0020502 (UMLS CUI [3])
C0020626 (UMLS CUI [4])
C1368019 (UMLS CUI [5])
Thyroid Disease Uncontrolled | Cushing Syndrome | Pituitary Disease
Item
no uncontrolled thyroid disease, cushing's disease, or other pituitary disease
boolean
C0040128 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0010481 (UMLS CUI [2])
C0032002 (UMLS CUI [3])
Bone Disease | Osteomalacia | Osteogenesis Imperfecta
Item
no other bone disease (including osteomalacia or osteogenesis imperfecta)
boolean
C0005940 (UMLS CUI [1])
C0029442 (UMLS CUI [2])
C0029434 (UMLS CUI [3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis
Item
more than 6 months since prior drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (stratum i)
boolean
C0013227 (UMLS CUI [1,1])
C3650929 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C3650929 (UMLS CUI [2,2])
C0012544 (UMLS CUI [3,1])
C3650929 (UMLS CUI [3,2])
Anticonvulsants
Item
more than 12 months since prior and no concurrent anticonvulsants
boolean
C0003286 (UMLS CUI [1])
Adrenal Cortex Hormones Dose Daily | Prednisone Dose Daily | Prednisone Equivalent Dose Daily
Item
more than 6 months since prior and no concurrent corticosteroids at doses > 5 mg/day of prednisone (or equivalent) for > 2 weeks
boolean
C0001617 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
C0032952 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0332173 (UMLS CUI [2,3])
C0032952 (UMLS CUI [3,1])
C0205163 (UMLS CUI [3,2])
C0178602 (UMLS CUI [3,3])
C0332173 (UMLS CUI [3,4])
Anabolic steroids
Item
more than 12 months since prior and no concurrent anabolic steroids
boolean
C0002845 (UMLS CUI [1])
Diphosphonates
Item
no prior bisphosphonates (stratum ii)
boolean
C0012544 (UMLS CUI [1])
Sodium Fluoride Dose Daily
Item
no concurrent sodium fluoride at daily doses ≥ 5 mg/day
boolean
C0037508 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0332173 (UMLS CUI [1,3])
Coumarins Long-term
Item
no long-term (i.e., > 6 months) use of coumarins
boolean
C0010207 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
Pharmaceutical Preparations Prevention of osteoporosis | Investigational New Drugs Prevention of osteoporosis | Diphosphonates Prevention of osteoporosis | Osteopenia | Osteoporosis
Item
no concurrent drugs (investigational or not), including bisphosphonates, for the prevention of osteoporosis (for patients with no osteopenia or osteoporosis [stratum i])
boolean
C0013227 (UMLS CUI [1,1])
C3650929 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C3650929 (UMLS CUI [2,2])
C0012544 (UMLS CUI [3,1])
C3650929 (UMLS CUI [3,2])
C0029453 (UMLS CUI [4])
C0029456 (UMLS CUI [5])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial